Alexander Aarvold, MBChB, FRCSEd(Tr&Orth), MFSTEd DM

Alexander Aarvold, MBChB, FRCSEd(Tr&Orth), MFSTEd DM

Alexander Aarvold, MBChB, FRCSEd(Tr&Orth), MFSTEd DM

Practice Information

  • Age groups you are accepting new hip dysplasia patients: Infants and children, Adolescents

Contact Information

  • Name: Alexander Aarvold
  • Degree: BSc(Hons,) MBChB, FRCSEd(Tr&Orth,) MFSTEd, DM
  • Title / Position: Consultant Paediatric Orthopaedic Surgeon
  • Place of Employment / Office Name: Southampton Children’s Hospital
  • Street Address: Tremona Road
  • City: Southampton
  • State/Province: Hampshire
  • Zip/Postal code: SO16 6YD
  • Country: United Kingdom
  • Office phone number: 02380 777222
  • Medical or Surgical Specialty: Pediatric Orthopadic Surgery

Professional Education and Memberships

  • Medical School: University of Edinburgh
  • Residency: St George’s Hospital, London, UK / Wessex Deanery, UK
  • Fellowship training: British Columbia (BC) Children’s Hospital, Vancouver, Canada
  • Certifications: General Medical Council, UK; Royal College of Surgeons of Edinburgh, UK
  • Society Memberships (list up to four only): British Orthopaedic Association (BOA)British Orthopaedic Research Society (BORS)World Orthopaedic Concern (WOC)International Perthes Study Group (IPSG)
  • Specific training in hip dysplasia: Fellowship in Pediatric Orthopaedic Surgery – BC Children’s Hospital, Vancouver, Canada
  • Academic contributions for DDH research or education including publications:
    • “A tissue engineering strategy for the treatment of avascular necrosis of the femoral head.”     Aarvold A, Smith JO, Tayton ER, Lanham SA, Briscoe A, Dunlop DG, Oreffo ROC.  The Surgeon 2013:11:319-25.
    • “Enhancing the osteogenic efficacy of human bone marrow aspirate –concentrating osteoprogenitors using wave-assisted filtration.” Aarvold A,* Dawson JI,* Smith JO,* Jones AMH, Ridgway JN, Curran SN, Higgs DR, Dunlop DG, Oreffo ROC. Cytotherapy 2012;15(2):242-52.
    • “Skeletal tissue regeneration – current approaches, challenges and novel reconstructive strategies.”Aarvold A,* Smith JO,* Tayton ER, Dunlop DG, Oreffo ROC. Tiss Eng Part B Rev 2011;17(5):307-20 Plus front cover image.
    • “Lessons in leadership from an international exchange visit.” Aarvold A, Ardolino A, Boyd R, Kelsall N, McGillion S, Hodkinson S, Goodwin M. International Journal of Clinical Leadership 2011;17(2):87-92 .
    • “Skeletal stem cells and bone regeneration: Translational strategies from bench to clinic.” Tare RS, Kanczler JM, Aarvold A, Jones AMH, Dunlop DG, Oreffo ROC. Proc. IMechE 2010;224(12) Part H: J.Engineering in Medicine:1455-70. Review
    • “Bone Tissue Engineering.” Dawson JI, Kanczler J, Smith JO, Aarvold A, Dunlop DG, Oreffo ROC. In: Comprehensive Biotechnology . Editors. Z Cui & L Brandon, Publisher: Elsevier, 2011.
    • “Skeletal stem cells: phenotype, nanotopography, biomimetic niche and translational biology.” Dawson JI, Kanczler J, Aarvold A, Kingham EJ, Oreffo RO. In: Stem Cells: Basic Biology and Clinical Applications, Editor: M Kassem, Publisher: King Saud University Press, 2011.
    • “Clinical applications for skeletal / mesenchymal stem cell therapy.” Tayton ER, Smith JO, Aarvold A, Oreffo RO, Zaleh W, Kassem M. In: Stem Cells: Basic Biology and Clinical Applications, Editor: M Kassem, Publisher: King Saud University Press, 2011.
    • “Dislocated but irreducible hips in infants aged <6 months. “ Mulpuri K, Aarvold A, Schaeffer E, Kelly S, Clarke NMP, Price C. International Hip Dysplasia Institute. Under revision for JPO.